ZA200709870B - Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity - Google Patents
Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activityInfo
- Publication number
- ZA200709870B ZA200709870B ZA200709870A ZA200709870A ZA200709870B ZA 200709870 B ZA200709870 B ZA 200709870B ZA 200709870 A ZA200709870 A ZA 200709870A ZA 200709870 A ZA200709870 A ZA 200709870A ZA 200709870 B ZA200709870 B ZA 200709870B
- Authority
- ZA
- South Africa
- Prior art keywords
- antibacterial activity
- aminopiperidine
- quinolines
- azaisosteric
- analogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68403005P | 2005-05-24 | 2005-05-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200709870B true ZA200709870B (en) | 2008-11-26 |
Family
ID=36685663
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200709870A ZA200709870B (en) | 2005-05-24 | 2007-11-15 | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
Country Status (14)
Country | Link |
---|---|
US (1) | US20090131444A1 (fr) |
EP (1) | EP1891078A1 (fr) |
JP (1) | JP2008542249A (fr) |
KR (1) | KR20080016577A (fr) |
CN (1) | CN101258157A (fr) |
AU (1) | AU2006250987A1 (fr) |
BR (1) | BRPI0609887A2 (fr) |
CA (1) | CA2608072A1 (fr) |
IL (1) | IL187134A0 (fr) |
MX (1) | MX2007014507A (fr) |
NO (1) | NO20076675L (fr) |
RU (1) | RU2007147413A (fr) |
WO (1) | WO2006125974A1 (fr) |
ZA (1) | ZA200709870B (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
CN101400674A (zh) * | 2006-03-10 | 2009-04-01 | 埃科特莱茵药品有限公司 | 抗生素化合物 |
DE602007009205D1 (de) | 2006-04-06 | 2010-10-28 | Glaxo Group Ltd | Pyrrolochinoxalinonderivate als antibakterielle mittel |
AU2007268749B2 (en) | 2006-05-26 | 2012-07-26 | Taisho Pharmaceutical Co., Ltd. | Novel heterocyclic compound or salt thereof and intermediate thereof |
BRPI0712430A2 (pt) * | 2006-06-08 | 2012-07-03 | Speedel Experimenta Ag | piperidinas 2,5-di-substitìdas. |
EA015821B1 (ru) * | 2007-04-20 | 2011-12-30 | Глэксо Груп Лимитед | Трициклические азотсодержащие соединения в качестве антибактериальных агентов |
TWI414290B (zh) | 2007-06-15 | 2013-11-11 | Actelion Pharmaceuticals Ltd | 3-胺基-6-(1-胺基-乙基)-四氫哌喃衍生物 |
AU2009215327A1 (en) | 2008-02-20 | 2009-08-27 | Actelion Pharmaceuticals Ltd | Azatricyclic antibiotic compounds |
CN102164925B (zh) | 2008-10-07 | 2015-04-08 | 埃科特莱茵药品有限公司 | 三环噁唑烷酮抗生素化合物 |
WO2010043714A1 (fr) | 2008-10-17 | 2010-04-22 | Glaxo Group Limited | Composés azotés tricycliques utilisés comme agents antibactériens |
PL2376497T3 (pl) | 2008-12-12 | 2014-03-31 | Idorsia Pharmaceuticals Ltd | Pochodne 5-amino-2-(1-hydroksyetylo)tetrahydropiranu |
WO2010126820A2 (fr) * | 2009-04-30 | 2010-11-04 | Merck Sharp & Dohme Corp. | Préparation d'esters alkyliques d'acides oxo-azacycloalkylcarboxyliques n-protégés |
BR112012025167B1 (pt) | 2010-04-02 | 2024-01-09 | Firmenich Incorporated | Modificador de sabor doce |
SG195289A1 (en) * | 2011-06-17 | 2013-12-30 | Astrazeneca Ab | Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof |
ES2607647T3 (es) | 2011-08-12 | 2017-04-03 | Senomyx, Inc. | Modificador del sabor dulce |
US8962843B2 (en) | 2012-03-30 | 2015-02-24 | Cubist Pharmaceuticals, Inc. | 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors |
AR090844A1 (es) * | 2012-04-27 | 2014-12-10 | Actelion Pharmaceuticals Ltd | Proceso para elaborar derivados de naftiridina |
US9120795B2 (en) | 2013-03-14 | 2015-09-01 | Cubist Pharmaceuticals, Inc. | Crystalline form of a β-lactamase inhibitor |
US9120796B2 (en) | 2013-10-02 | 2015-09-01 | Cubist Pharmaceuticals, Inc. | B-lactamase inhibitor picoline salt |
CN103613530B (zh) * | 2013-12-02 | 2015-08-19 | 江苏弘和药物研发有限公司 | 一种芴甲氧羰基-3-哌啶醇的合成方法 |
JP6687238B2 (ja) | 2013-12-27 | 2020-04-22 | 株式会社エーピーアイ コーポレーション | 5−ヒドロキシピペリジン−2−カルボン酸の製造方法 |
CN106659717B (zh) | 2014-08-22 | 2019-09-06 | 葛兰素史密斯克莱知识产权发展有限公司 | 用于治疗淋病奈瑟球菌感染的三环含氮化合物 |
US11339128B2 (en) | 2014-11-07 | 2022-05-24 | Firmenich Incorporated | Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavor modifiers |
TW201722965A (zh) * | 2015-08-16 | 2017-07-01 | 葛蘭素史密斯克藍智慧財產發展有限公司 | 用於抗菌應用之化合物 |
PL3468975T3 (pl) | 2016-06-08 | 2020-09-07 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Nowe związki przeciwbakteryjne |
AU2017295863B2 (en) | 2016-07-13 | 2022-07-07 | Syros Pharmaceuticals, Inc. | Inhibitors of cyclin-dependent kinase 7 (CDK7) |
JP7210483B2 (ja) | 2017-06-30 | 2023-01-23 | バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 新規アザキノリン誘導体 |
JP2020530446A (ja) | 2017-08-09 | 2020-10-22 | デナリ セラピューティクス インコーポレイテッドDenali Therapeutics Inc. | 化合物、組成物、及び、方法 |
JP7382308B2 (ja) * | 2017-09-01 | 2023-11-16 | デナリ セラピューティクス インコーポレイテッド | 化合物、組成物、及び、方法 |
BR112020005174A2 (pt) | 2017-09-14 | 2020-11-10 | Daiichi Sankyo Company,Limited | composto que possui estrutura cíclica |
MX2021009669A (es) | 2019-02-13 | 2021-10-13 | Denali Therapeutics Inc | Compuestos, composiciones y métodos. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9822450D0 (en) * | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
US6962917B2 (en) * | 2000-07-26 | 2005-11-08 | Smithkline Beecham P.L.C. | Aminopiperidine quinolines and their azaisosteric analogues with antibacterical activity |
EP1719770A3 (fr) * | 2000-09-21 | 2008-03-05 | Smithkline Beecham Plc | Dérivés de quinoline comme agents antibactériens |
WO2006032466A2 (fr) * | 2004-09-24 | 2006-03-30 | Actelion Pharmaceuticals Ltd | Nouveaux antibiotiques bicycliques |
-
2006
- 2006-05-23 KR KR1020077027342A patent/KR20080016577A/ko not_active Application Discontinuation
- 2006-05-23 CN CNA2006800266719A patent/CN101258157A/zh active Pending
- 2006-05-23 WO PCT/GB2006/001889 patent/WO2006125974A1/fr active Application Filing
- 2006-05-23 CA CA002608072A patent/CA2608072A1/fr not_active Abandoned
- 2006-05-23 US US11/914,799 patent/US20090131444A1/en not_active Abandoned
- 2006-05-23 MX MX2007014507A patent/MX2007014507A/es not_active Application Discontinuation
- 2006-05-23 EP EP06743966A patent/EP1891078A1/fr not_active Withdrawn
- 2006-05-23 AU AU2006250987A patent/AU2006250987A1/en not_active Abandoned
- 2006-05-23 BR BRPI0609887-8A patent/BRPI0609887A2/pt not_active Application Discontinuation
- 2006-05-23 JP JP2008512908A patent/JP2008542249A/ja active Pending
- 2006-05-23 RU RU2007147413/04A patent/RU2007147413A/ru not_active Application Discontinuation
-
2007
- 2007-11-04 IL IL187134A patent/IL187134A0/en unknown
- 2007-11-15 ZA ZA200709870A patent/ZA200709870B/xx unknown
- 2007-12-27 NO NO20076675A patent/NO20076675L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2007147413A (ru) | 2009-06-27 |
CA2608072A1 (fr) | 2006-11-30 |
AU2006250987A1 (en) | 2006-11-30 |
CN101258157A (zh) | 2008-09-03 |
IL187134A0 (en) | 2008-02-09 |
JP2008542249A (ja) | 2008-11-27 |
WO2006125974A1 (fr) | 2006-11-30 |
KR20080016577A (ko) | 2008-02-21 |
US20090131444A1 (en) | 2009-05-21 |
EP1891078A1 (fr) | 2008-02-27 |
BRPI0609887A2 (pt) | 2011-10-11 |
NO20076675L (no) | 2007-12-27 |
MX2007014507A (es) | 2008-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL187134A0 (en) | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity | |
HK1124784A1 (en) | Quinolines and their pharmaceutic use | |
ZA200900204B (en) | Substituted piperidines that increase P53 activity and the uses thereof | |
IL188420A0 (en) | Methods and compositions with enhanced therapeutic activity | |
IL228770A0 (en) | processes and intermediates | |
EP1889195A4 (fr) | Fabrication et conception tenant compte l'une de l'autre | |
IL192845A0 (en) | Benzamide and heteroarene derivatives | |
IL185280A0 (en) | Tetrahydroindolone and tetrahydroindazolone derivatives | |
EP1878346A4 (fr) | Agent antibacterien inorganique a base d'argent et produit antibacterien | |
EP1941925A4 (fr) | Jeu de seringue et etui protecteur | |
HK1125626A1 (en) | Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity | |
IL179236A (en) | Griffithsin and its antiviral resistant glycosylation variants and related methods | |
ZA200709818B (en) | Articulated and/or bearing arrangement | |
GB0516069D0 (en) | Pharmaceutical and use thereof | |
PT2380575E (pt) | Acetato de eslicarbazepina e utilização | |
HK1121759A1 (zh) | 烷基磺酰胺喹啉 | |
EP1931209A4 (fr) | Solutions antimicrobiennes et procedes associe | |
IL189849A0 (en) | Interferon-beta and optic neuritis | |
EP1869022A4 (fr) | Dérivés de naphtalamide ayant une activité antiproliférative | |
EP1867656A4 (fr) | Compose a structure cyclique et son utilisation | |
ZA200802683B (en) | Quinolines and their therapeutic use | |
IL188241A0 (en) | Cripowellins and synthetic derivatives thereof used as medicaments | |
HRP20040318A2 (en) | Furochromen derivative with anti-inflammaroty activity | |
HK1216635A1 (zh) | 具血清素激活及/或去甲腎上腺素活動的代苯乙胺 | |
GB0521886D0 (en) | Glycosyltrasferase activity |